A new high-dose chemotherapy regimen has been shown to improve survival of children with high-risk neuroblastoma, a common pediatric cancer, according to a European clinical trial published Sunday.
Jun 06, 2011
not rated yet
1
Researchers at Duke University Medical Center have just completed a clinical trial that showed it is possible to study a new combination of drugs against a melanoma recurrence that has not spread beyond a limb. Using a fairly ...
Feb 24, 2011
2 / 5 (1)
0
The first study of its kind comparing two different approaches to treating newly diagnosed multiple myeloma has found that both treatments achieved a positive response, researchers said at the 35th Congress of the European ...
Oct 12, 2010
not rated yet
0
